Clinical Case Report on Setmelanotide Treatment for a 2-Year-Old Patient

A single-patient case report documents 23 months of setmelanotide treatment for a 2-year-old child with leptin receptor deficiency. The report details clinical outcomes including changes in hyperphagia, body mass index, motor skills, and adverse events. It provides qualitative and quantitative observations from a rare pediatric treatment scenario.

Use Cases

• Analyze the timeline of setmelanotide dose escalation from 0.5 mg/day to 2.5 mg/day documented in the case description.
• Correlate reported clinical improvements in hyperphagia and food-seeking behavior with the 23-month treatment duration.
• Review documented adverse events, such as skin rash and hyperpigmentation, associated with setmelanotide administration.
• Examine the relationship between treatment initiation and reported improvements in motor skill milestones like crawling and kneeling.

Strengths

• Provides detailed longitudinal data covering a 23-month treatment and observation period.
• Focuses on a rare clinical population: a 2-year-old patient with leptin receptor deficiency.
• Documents specific treatment parameters, including dose increments and administration method (subcutaneous injection).
• Includes multiple outcome measures: hyperphagia, BMI, motor skills, and adverse events.

Limitations

• Sample size is one patient, limiting statistical power and generalizability of findings.
• Data is qualitative and narrative from a case report, not structured quantitative data for direct computational analysis.
• Temporal coverage is specific to a single case from 2021 to 2025, not a continuous time series.

Provenance

Source

figshare

Collection Method

Clinical case report authored by medical researchers.

Time Range

Treatment and observation from March 2023, following a May 2021 diagnosis.

Freshness

null

Geography

null